{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:21:35Z","timestamp":1774509695941,"version":"3.50.1"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neulet.2021.135865","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T20:56:09Z","timestamp":1617310569000},"page":"135865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy"],"prefix":"10.1016","volume":"753","author":[{"given":"Violina","family":"Kakoty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarathlal","family":"K C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-769X","authenticated-orcid":false,"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Taliyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.135865_bib0005","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.parkreldis.2013.07.010","article-title":"Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson\u2019s disease","volume":"19","author":"M\u00fcller","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neulet.2021.135865_bib0015","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2021.135865_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbr.2018.05.025","article-title":"High fat diet feeding induced insulin resistance exacerbates 6-OHDA mediated neurotoxicity and behavioral abnormalities in rats","volume":"351","author":"Sharma","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2021.135865_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0035","series-title":"J. Neurochem.","first-page":"110","article-title":"Histone deacetylase inhibitor, SAHA, ameliorated the toxic effects of high fat diet induced insulin resistance in Hemiparkinson\u2019s","author":"Sharma","year":"2017"},{"key":"10.1016\/j.neulet.2021.135865_bib0040","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jns.2017.08.2198","article-title":"Histone deacetylase inhibitor, Valproic acid, ameliorates insulin resistance induced cognitive deficit in mice","volume":"381","author":"Sharma","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2021.135865_bib0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neulet.2021.135865_bib0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(91)90073-Q","article-title":"MPTP mechanisms of neurotoxicity and their implications for Parkinson\u2019s disease","volume":"208","author":"Gerlach","year":"1991","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135865_bib0055","doi-asserted-by":"crossref","first-page":"19126","DOI":"10.1073\/pnas.0508215102","article-title":"Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage","volume":"102","author":"Perier","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2021.135865_bib0060","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","article-title":"Calcium entry and \u03b1-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons","volume":"33","author":"Dryanovski","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","article-title":"\u03b1-Synuclein is localized to mitochondria-associated ER membranes","volume":"34","author":"Guardia-Laguarta","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"\u03b1-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neulet.2021.135865_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1073\/pnas.0710685105","article-title":"The Parkinson\u2019s disease protein \u03b1-synuclein disrupts cellular Rab homeostasis","volume":"105","author":"Gitler","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2021.135865_bib0080","first-page":"3","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","author":"Koprich","year":"2017","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.neulet.2021.135865_bib0085","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in \u03b1-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2021.135865_bib0090","first-page":"E1926","article-title":"\u03b1-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation","volume":"112","author":"Wang","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2021.135865_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2021.135865_bib0100","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","article-title":"Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human \u03b1-synuclein (1--120): implications for Lewy body disorders","volume":"26","author":"Tofaris","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nbd.2016.12.008","article-title":"Effects of \u03b1-synuclein on axonal transport","volume":"105","author":"Volpicelli-Daley","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2021.135865_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110145","article-title":"Fibroblast growth factor 21 and autophagy: a complex interplay in Parkinson disease","volume":"127","author":"Kakoty","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neulet.2021.135865_bib0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2021.135865_bib0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric \u03b1-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2021.135865_bib0125","doi-asserted-by":"crossref","DOI":"10.5688\/aj710478","article-title":"Physiology of the autonomic nervous system","volume":"71","author":"McCorry","year":"2007","journal-title":"Am. J. Pharm. Educ."},{"key":"10.1016\/j.neulet.2021.135865_bib0130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/archsurg.1992.01420120097017","article-title":"The hypothalamic-pituitary-adrenal\u2014Immune axis: a critical assessment","volume":"127","author":"Lilly","year":"1992","journal-title":"Arch. Surg."},{"key":"10.1016\/j.neulet.2021.135865_bib0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0145","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2021.135865_bib0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neures.2006.11.012","article-title":"CARD15 variants in patients with sporadic Parkinson\u2019s disease","volume":"57","author":"Bialecka","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2021.135865_bib0155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared g","volume":"47","author":"Liu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neulet.2021.135865_bib0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2021.135865_bib0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12974-016-0608-5","article-title":"Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration","volume":"13","author":"Pellegrini","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2021.135865_bib0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/mds.27237","article-title":"Cyclooxygenase 2 is upregulated in the gastrointestinal tract in Parkinson\u2019s disease","volume":"33","author":"Pochard","year":"2018","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neulet.2021.135865_bib0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.27326","article-title":"Stool immune profiles evince gastrointestinal inflammation in Parkinson\u2019s disease","volume":"33","author":"Houser","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0185","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-physiol-021115-105439","article-title":"Enteroendocrine cells: chemosensors in the intestinal epithelium","volume":"78","author":"Gribble","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neulet.2021.135865_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089881","article-title":"An enteroendocrine cell--enteric glia connection revealed by 3D electron microscopy","volume":"9","author":"Boh\u00f3rquez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2021.135865_bib0200","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92295","article-title":"\u03b1-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease","volume":"2","author":"Chandra","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.neulet.2021.135865_bib0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","article-title":"Pattern of brain destruction in Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"103","author":"Braak","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neulet.2021.135865_bib0210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neulet.2021.135865_bib0215","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/mds.21560","article-title":"Bowel movement frequency in late-life and incidental Lewy bodies","volume":"22","author":"Abbott","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neulet.2021.135865_bib0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","article-title":"Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre-and postganglionic neurons","volume":"113","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2021.135865_bib0225","series-title":"The Functional Anatomy of Basal Ganglia Disorders","author":"Albin","year":"1989"},{"key":"10.1016\/j.neulet.2021.135865_bib0230","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0235","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.25789","article-title":"Alimentary, my dear Watson? The challenges of enteric \u03b1-synuclein as a Parkinson\u2019s disease biomarker","volume":"29","author":"Visanji","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JPD-140422","article-title":"Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD","volume":"4","author":"Corbill\u00e9","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neulet.2021.135865_bib0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2021.135865_bib0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/apha.12229","article-title":"The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra","volume":"211","author":"Zheng","year":"2014","journal-title":"Acta Physiol."},{"key":"10.1016\/j.neulet.2021.135865_bib0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease","volume":"29","author":"Kelly","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0260","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0265","series-title":"An Essay on the Shaking Palsy: Sherwood","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.neulet.2021.135865_bib0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","article-title":"Pains in Parkinson disease\u2014many syndromes under one umbrella","volume":"8","author":"Wasner","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0006-8993(88)90971-7","article-title":"Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat","volume":"447","author":"Baumeister","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2021.135865_bib0280","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/jnnp.2007.120212","article-title":"Levodopa raises objective pain threshold in Parkinson\u2019s disease: a RIII reflex study","volume":"78","author":"Gerdelat-Mas","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neulet.2021.135865_bib0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mds.23406","article-title":"Apomorphine effect on pain threshold in Parkinson\u2019s disease: a clinical and positron emission tomography study","volume":"26","author":"Dellapina","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson\u2019s disease","volume":"12","author":"Gonera","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0295","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","article-title":"Anxiety disorders in Parkinson\u2019s disease: prevalence and risk factors","volume":"25","author":"Dissanayaka","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u2014Epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0305","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human \u03b1-synuclein in midbrain dopaminergic neurons","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neulet.2021.135865_bib0315","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing \u03b1-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2021.135865_bib0320","series-title":"Anatomy of the Vagus Nerves in the Region of the Lower Esophagus and the Stomach","author":"Jackson","year":"1949"},{"key":"10.1016\/j.neulet.2021.135865_bib0325","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","article-title":"Vagotomy and Parkinson disease: a Swedish register--based matched-cohort study","volume":"88","author":"Liu","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2021.135865_bib0330","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2016.04.002","article-title":"Vagotomy and subsequent development of diabetes--A nested case--control study","volume":"65","author":"Starup-Linde","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.neulet.2021.135865_bib0335","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of P arkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2021.135865_bib0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000145955","article-title":"Retrograde degeneration within the dorsal motor yagal nucleus following bilateral vagotomy in rabbits","volume":"121","author":"Szereda-Przestaszewska","year":"1985","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.neulet.2021.135865_bib0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.26479","article-title":"Synaptic failure and \u03b1-synuclein","volume":"31","author":"Calo","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0350","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0355","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518786715","article-title":"Testing the protein propagation hypothesis of Parkinson disease","volume":"12","author":"Dagher","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0360","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2021.135865_bib0365","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/emmm.201302475","article-title":"Caudo-rostral brain spreading of \u03b1-synuclein through vagal connections","volume":"5","author":"Ulusoy","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neulet.2021.135865_bib0370","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","article-title":"The gut-brain axis in Parkinson\u2019s disease: possibilities for food-based therapies","volume":"817","author":"Perez-Pardo","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2021.135865_bib0375","series-title":"Adv. Carbohydr. Chem.","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0096-5332(08)60243-X","article-title":"Trehaloses","author":"Birch","year":"1963"},{"key":"10.1016\/j.neulet.2021.135865_bib0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00239-014-9645-9","article-title":"Why can\u2019t vertebrates synthesize trehalose?","volume":"79","author":"Arg\u00fcelles","year":"2014","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.neulet.2021.135865_bib0385","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.7754360","article-title":"Amorphous stability and trehalose","volume":"268","author":"Colaco","year":"1995","journal-title":"Science (80-.)"},{"key":"10.1016\/j.neulet.2021.135865_bib0390","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0011-2240(90)90017-X","article-title":"The basis for toxicity of certain cryoprotectants: a hypothesis","volume":"27","author":"Arakawa","year":"1990","journal-title":"Cryobiology"},{"key":"10.1016\/j.neulet.2021.135865_bib0395","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/abbi.1999.1175","article-title":"Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding","volume":"365","author":"Allison","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neulet.2021.135865_bib0400","series-title":"Water Relationships in Foods","first-page":"29","article-title":"A food polymer science approach to structure-property relationships in aqueous food systems: non-equilibrium behavior of carbohydrate-water systems","author":"Slade","year":"1991"},{"key":"10.1016\/j.neulet.2021.135865_bib0405","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1128\/jb.169.11.4995-5001.1987","article-title":"Effects of intracellular trehalose content on Streptomyces griseus spores","volume":"169","author":"McBRIDE","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.neulet.2021.135865_bib0410","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0305-0491(81)90299-6","article-title":"Anhydrobiosis in nematodes\u2014I. The role of glycerol myo-inositol and trehalose during desiccation","volume":"70","author":"Womersley","year":"1981","journal-title":"Comp. Biochem. Physiol. Part B Comp. Biochem."},{"key":"10.1016\/j.neulet.2021.135865_bib0415","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1097-2765(00)80064-7","article-title":"Multiple effects of trehalose on protein folding in vitro and in vivo","volume":"1","author":"Singer","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neulet.2021.135865_bib0420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","article-title":"Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease","volume":"10","author":"Tanaka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2021.135865_bib0425","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","article-title":"Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42","volume":"20","author":"Liu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2021.135865_bib0430","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/auto.25188","article-title":"Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons","volume":"9","author":"Castillo","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.neulet.2021.135865_bib0435","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbrc.2008.06.094","article-title":"Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage","volume":"374","author":"B\u00e9ranger","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2021.135865_bib0440","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.neuint.2011.01.008","article-title":"The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells","volume":"58","author":"Casarejos","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2021.135865_bib0445","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bbrc.2015.08.076","article-title":"Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease","volume":"465","author":"Tanji","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2021.135865_bib0450","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and \u03b1-synuclein","volume":"282","author":"Sarkar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2021.135865_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-gut-brain signalling in Parkinson\u2019s disease: implications for non-motor symptoms","volume":"27","author":"Felice","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0460","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00439-013-1278-3","article-title":"Identification of genetic variation that determines human trehalase activity and its association with type 2 diabetes","volume":"132","author":"Muller","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neulet.2021.135865_bib0465","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/acschemneuro.7b00177","article-title":"Biosynthesis of astrocytic trehalose regulates neuronal arborization in hippocampal neurons","volume":"8","author":"Martano","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neulet.2021.135865_bib0470","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2021.135865_bib0475","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"\u03b1-Synuclein immunotherapy blocks uptake and templated propagation of misfolded \u03b1-synuclein and neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neulet.2021.135865_bib0480","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/biof.5520180208","article-title":"Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential","volume":"18","author":"Menke","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.neulet.2021.135865_bib0485","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.abb.2014.05.017","article-title":"Polyphenols and mitochondria: an update on their increasingly emerging ROS-scavenging independent actions","volume":"559","author":"Sandoval-Acu\u00f1a","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neulet.2021.135865_bib0490","series-title":"Parkinson\u2019s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","author":"N.C.C. for Chronic Conditions (Great Britain)","year":"2006"},{"key":"10.1016\/j.neulet.2021.135865_bib0495","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0022-3565(25)28524-X","article-title":"Potentiation and inhibition of some central actions of l (\u2014)-DOPA by decarboxylase inhibitors","volume":"172","author":"Lotti","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2021.135865_bib0500","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<294::AID-SYN3>3.0.CO;2-7","article-title":"Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment","volume":"27","author":"de Souza Silva","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2021.135865_bib0505","first-page":"33","article-title":"Update on ropinirole in the treatment of Parkinson\u2019s disease","volume":"5","author":"Shill","year":"2009","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2021.135865_bib0510","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0031-6997(25)06826-7","article-title":"Bromocriptine in Parkinson disease","volume":"37","author":"Lieberman","year":"1985","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2021.135865_bib0515","first-page":"1","article-title":"Apomorphine for Parkinson\u2019s disease: efficacy and safety of current and new formulations","author":"Carbone","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2021.135865_bib0520","series-title":"Dopamine Agonists: Their Role in the Treatment of Parkinson\u2019s Disease","author":"Brooks","year":"2000"},{"key":"10.1016\/j.neulet.2021.135865_bib0525","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/NDT.S2325","article-title":"Update on the use of pramipexole in the treatment of Parkinson\u2019s disease","volume":"4","author":"Constantinescu","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2021.135865_bib0530","series-title":"StatPearls [Internet]","article-title":"Dopamine agonists","author":"Choi","year":"2019"},{"key":"10.1016\/j.neulet.2021.135865_bib0535","series-title":"Mov. Disord.","first-page":"348","article-title":"Dopamine receptors in movement disorders","author":"Calne","year":"1981"},{"key":"10.1016\/j.neulet.2021.135865_bib0540","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40265-015-0377-y","article-title":"An update on pharmacological, pharmacokinetic properties and drug--drug interactions of rotigotine transdermal system in Parkinson\u2019s disease and restless legs syndrome","volume":"75","author":"Elshoff","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.neulet.2021.135865_bib0545","series-title":"Pharmacological Treatment of Parkinson\u2019s Disease","first-page":"129","author":"Zahoor","year":"2018"},{"key":"10.1016\/j.neulet.2021.135865_bib0550","first-page":"23","article-title":"Rasagiline in treatment of Parkinson\u2019s disease","volume":"4","author":"Nayak","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2021.135865_bib0555","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2147\/TCRM.S139545","article-title":"Safinamide in the management of patients with Parkinson\u2019s disease not stabilized on levodopa: a review of the current clinical evidence","volume":"14","author":"Bette","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.neulet.2021.135865_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S2404","article-title":"COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson\u2019s disease (PD): relevance for motor and non-motor features","volume":"4","author":"Antonini","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2021.135865_bib0565","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/DDDT.S104227","article-title":"Spotlight on opicapone as an adjunct to levodopa in Parkinson\u2019s disease: design, development and potential place in therapy","volume":"11","author":"Annus","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.neulet.2021.135865_bib0570","first-page":"39","article-title":"Anticholinergic drugs used in Parkinson\u2019s disease: an overlooked class of drugs from a pharmacokinetic perspective","volume":"2","author":"Brocks","year":"1999","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.neulet.2021.135865_bib0575","first-page":"590","article-title":"Medical management of Parkinson\u2019s disease","volume":"33","author":"Goldenberg","year":"2008","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.neulet.2021.135865_bib0580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015298","article-title":"Amantadine for dyskinesias in Parkinson\u2019s disease: a randomized controlled trial","volume":"5","author":"Sawada","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2021.135865_bib0585","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/humc.2018.081","article-title":"Long-term follow-up of a phase I\/II study of ProSavin, a lentiviral vector gene therapy for Parkinson\u2019s disease","volume":"29","author":"Palfi","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.neulet.2021.135865_bib0590","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2217\/nmt-2017-0027","article-title":"Parkinson\u2019s disease and the quest for preclinical diagnosis: an interview with professor Werner Poewe","volume":"7","author":"Poewe","year":"2017","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.neulet.2021.135865_bib0595","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","article-title":"First-in-human assessment of PRX002, an anti--\u03b1-synuclein monoclonal antibody, in healthy volunteers","volume":"32","author":"Schenk","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2021.135865_bib0600","series-title":"Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Anti-Alpha-Synuclein Antibody BIIB054 in Patients with Parkinson\u2019s Disease (S26. 001)","author":"Brys","year":"2018"},{"key":"10.1016\/j.neulet.2021.135865_bib0605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","article-title":"Nilotinib-induced autophagic changes increase endogenous Parkin level and ubiquitination, leading to amyloid clearance","volume":"92","author":"Lonskaya","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neulet.2021.135865_bib0610","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson\u2019s disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2021.135865_bib0615","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1177\/0963689717721234","article-title":"A new treatment strategy for Parkinson\u2019s disease through the gut--brain axis: the glucagon-like peptide-1 receptor pathway","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Transplant."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:39:17Z","timestamp":1759610357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":123,"alternative-id":["S0304394021002433"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135865","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.135865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"135865"}}